Vancomycin Exposure and Biomarker Tracking Using Real-time Monitoring of Interstitial Fluid
Key facts
- Who runs it
- Nutromics
- Where
- New Hyde Park, New York, Oakland, San Francisco, and Stanford, United StatesSee the 5 sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 200 people, planned
- Starts
- Dec 2026
- Expected to end
- Dec 2028
- Type of study
- Observational, 2 groups
- Record updated
- 23 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Capable of providing informed consent OR has a Medical Treatment Decision Maker who can provide informed consent per the informed consent form (ICF)
- Aged 18 years at time of enrolment
- Prescribed vancomycin treatment for intravenous administration (Cohort 1 only); vancomycin treatment duration expected to be ≥48 hours from time of enrolment
- Has a central or arterial catheter and/or a large-bore cannula, or is willing to have intermittent peripheral blood sampling
Who cannot take part
- Currently receiving an investigational drug or device that, in the Investigator's opinion, may affect participation in this trial
- History of allergic reactions to metals, plastics and adhesives which, in the opinion of the Study Investigators, would increase the risk of allergic reaction associated with the Device
- Dermatological (or other) condition, or fragile skin, which in the opinion of the Investigators would prevent application of the Nutromics Sensor Device
- Severe oedema or local swelling at the intended application site that would likely impair ISF sampling
- Immediate life-threatening instability where study procedures would interfere with urgent care (participant may be screened once stable)
- Pregnant, lactating, planning to become pregnant, breastfeed, or donate ova
Where in United States
- Northwell HealthNew Hyde Park, United StatesNot yet recruiting
- Columbia UniversityNew York, United StatesNot yet recruiting
- Kaiser PermanenteOakland, United StatesNot yet recruiting
- University of California San FranciscoSan Francisco, United StatesNot yet recruiting
- StanfordStanford, United StatesNot yet recruiting
About the trial
What the trial wants to find out
The goal of this observational study is to understand whether a wearable sensor (the Nutromics Sensor Device) can accurately measure drug and biomarker levels in the fluid just under the skin (interstitial fluid), instead of needing repeated blood draws, in adults admitted to hospital who are being treated with the antibiotic vancomycin or who are being monitored for signs of sepsis. The main questions it aims to answer are:
Read full original descriptionShow less
* How closely do interstitial fluid levels of vancomycin match levels measured in the blood at the same time? * How closely do interstitial fluid levels of creatinine, C-reactive protein, and lactate (biomarkers linked to kidney function, inflammation, and infection severity) match levels measured in the blood? * Can the device pick up on early biomarker trends that signal a patient may be developing acute kidney injury? * How well does the device work overall, and does it perform consistently across different patients (by age, sex, ethnicity, body size, and health conditions) and over time? * Is the device safe to wear?
There is no comparison group receiving a different treatment. This study looks at how well the device's readings line up with standard blood tests, not about testing a new treatment.
Participants will:
* Wear up to two small sensor patches on their upper arm during their hospital stay (up to 5 days), with each patch replaced every 48 hours * Have blood samples taken as part of their routine care so results can be compared * Have their medical records reviewed 30 days after finishing the study to check on their health outcomes
The 2 groups in the trial
- Cohort 1
Hospitalised participants receiving vancomycin (Vancomycin monitoring)
- Cohort 2
Hospitalised participants not receiving vancomycin (Biomarker Monitoring)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Vancomycin Exposure, Nephrotoxicity, and Sepsis Biomarker Tracking Using Real-time Monitoring of Interstitial Fluid
- Record updated
- 23 October 2026